Prof. Patrick W. Serruys

Patrick W. Serruys

Interventional cardiologist / Cardiologist
Imperial College - Rotterdam, Netherlands

Patrick W. Serruys (1947-)
 

In 2005 he held the 4th International Lecture at the AHA and Mikamo Lecture at the Japanese heart Association.

In 2006 he received the highest award of the Clinical Council of the American Heart Association: the James Herrick Award. In 2007 he received the Arrigo Recordati International Prize (Italy) and the ICI Achievement Award (bestowed by the President of Israel – Shimon Perez). In 2008 he received the Einthoven Penning (Leiden). In 2009 he became Doctor Honoris Causa from the University of Athens.

In 2011 he received the Lifetime Achievement Award, bestowed by the American College of Cardiology, in recognition of many years of service and invaluable contributions to the ACC. At the end of 2011 Dr Serruys received the Ray C. Fish Award, bestowed by the Texas Heart Institute, for outstanding achievement and contribution to cardiovascular medicine.

Diplomas

YearDiploma
1965 - 1968Pre clinical medical studies, summa cum laude - University of Leuven, Belgium
1968 - 1972Clinical studies, summa cum laude - University of Leuven, Belgium
1972Internal medicine examination, Second of 29 candidates - University of Leuven, Belgium
1972Medical degree, summa cum laude, Dux of class of 313 candidates
1972 - 1973Internship. Rotations in internal and pulmonary medicine - University of Leuven, Belgium
1973Rotation in hematology - University of Leuven, Belgium
1973 - 1975Rotation in the intensive care and coronary care units. Prof. Tremouroux - University of Leuven, Belgium
1975Cardiac surgery and post operative care. Prof. Chalant - University of Leuven, Belgium
1975 - 1976Department of Cardiology. Prof. Basseur - University of Leuven, Belgium
1976Department of Cardiology. Prof. Kremer - University of Leuven, Belgium
1976 - 1985Department of Cardiology. Prof. Hugenholtz - Erasmus University, Rotterdam, The Netherlands. Certification as Cardiologist in Belgium and The Netherlands

Clinical career

YearFunction + center
1977Senior Member of Cardiology Staff of the Thoraxcenter, Prof. Hugenholtz - Erasmus University, Rotterdam, The Netherlands
1977 - 1980Co director of the Catheterization Laboratory, Thoraxcenter - Erasmus University, Rotterdam, The Netherlands
1980Present Director of the Clinical Research Program of the Catheterization Laboratory and the Clinical Imaging Laboratory for angiography
1983Correspondent of the French Society of Cardiology
1984Chairman of the Working Group on Coronary Blood Flow and Angina Pectoris (European Society of Cardiology)
1986Appointed to \"Chef de Clinique\", and defended cum laude his PhD thesis on: Transluminal coronary angioplasty: an investigational tool and a non operative treatment of acute myocardial ischemia
1988Nomination as professor of interventional cardiology ("hoogleraar in interventie cardiologie") in the Interuniversity Cardiological Institute of the Netherlands (ICIN)
1997Head of the Interventional Dept. Heartcenter Rotterdam, The Netherlands

Latest contributions

Is survival and cause of death really different after TAVI? Surprising insights from Denmark

Under the leadership of Lars Søndergrad, the Rigs Hospital in Denmark is publishing a paper entitled “Survival and cause of death after transcatheter aortic valve replacement as compared to an age- and sex-matched background population”. As a small country, Danish physicians and healthcare delivery are extremely well organised, with complex treatments centralised in a few hospitals with great expertise, thus data collection is greatly enhanced.

The Tendyne device: a breakthrough in mitral valve replacement

Over the last few years, we have seen an explosion of devices targeting the repair or replacement of the mitral valve. Five years ago, there was tremendous hype in the field which generated the impression that many of these devices would be a good and permanent solution for patients with mitral disease that could not be treated surgically.

What is it to become an octogenarian 40 years after the first angioplasty?

In 1985, four pioneers, Charles Dotter, Melvin Judkins, Mason Sones, and Andreas Grüntzig died in the same year. They have probably opened a wonderful diagnostic and interventional suite together in heaven.

Authors :

Patrick W. Serruys

EuroIntervention Journal: What is it to become an octogenarian 40 years after the first angioplasty?

In 1985, four pioneers, Charles Dotter, Melvin Judkins, Mason Sones, and Andreas Grüntzig died in the same year. They have probably opened a wonderful diagnostic and interventional suite together in heaven.

Prof. Patrick W. Serruys

Author

Patrick W. Serruys

Long-term data of BRS

19 May 2017 – From EuroPCR 2017

Burning questions and meet the pioneers

19 May 2017 – From EuroPCR 2017

The year in intervention: essential publications from the EuroIntervention Journal and the European Heart Journal

18 May 2017 – From EuroPCR 2017

EAPCI General Assembly

18 May 2017 – From EuroPCR 2017

Consult this session on the EAPCI General Assembly held in Paris during EuroPCR 2017.

Clinical outcome data from DEFINE-FLAIR and iFR-SWEDEHEART: implications for coronary revascularisation practice with iFR co-registration  

17 May 2017 – From EuroPCR 2017

Bioresorbable valve therapy: tomorrow's world

17 May 2017 – From EuroPCR 2017

Complex patients with multivessel disease - From triage of patient to treatment: the future is now

17 May 2017 – From EuroPCR 2017

Bioresorbable scaffold thrombosis: what have we learnt?

16 May 2017 – From EuroPCR 2017

Consult this session about what have we learnt about bioresorbable scaffold thrombosis presented by D. Capodanno, M. Joner, T. F. Lüscher, Y. Onuma, P. Serruys and N. West. Review incidence and predictors of bioresorbable scaffold thrombosis and gain insights about the mechanism underlying scaffold thrombosis and ongoing treatment.

TAVI procedural guidance by angiography - Quantification by video-densitometry

16 May 2017 – From EuroPCR 2017

How a unique DES platform translates into clinical differentiation with MiStent: from premise to proven effectiveness

16 May 2017 – From EuroPCR 2017

Innovations at the crossroad: bioresorbable scaffolds

15 May 2017 – From PCR Innovators Day Paris 2017

Consult this innovation session on bioresorbable scaffolds presented by Speaker: P.W. Serruys during PCR Innovators Day Paris 2017.

At the crossroads of BRS development: food for thought

31 Jan 2017

 
It is clear that we have reached a crossroads with the new technology which we call the "fully bioresorbable scaffold". Today, the community is somewhat insecure about the future of this new technology which is currently still in its early iterations.

NOBLE and EXCEL - Will these trials change my practice?

19 Jan 2017 – From AsiaPCR/SingLIVE 2017

Dr. Marie-Claude Morice

Chairperson

Marie-Claude Morice
Prof. Shigeru Saito

Chairperson

Shigeru Saito

AsiaIntervention / Clinical Research

19 Jan 2017 – From AsiaPCR/SingLIVE 2017

Mitral and tricuspid

19 May 2016 – From EuroPCR 2016

Dr. Nicolo Piazza

Chairperson

Nicolo Piazza
Dr. Alec Vahanian

Chairperson

Alec Vahanian

Transcatheter mitral valve replacement: new valves and experiences

20 May 2015 – From EuroPCR 2015

Consult this session on innovation in new valves and experiences in transcatheter mitral valve replacement.

Implantation of bioresorbable vascular scaffolds: the optimal technique

17 Dec 2015 – From GulfPCR-GIM 2015

This video is offered by Abbott Vascular

Dr. Jean Fajadet

Chairperson

Jean Fajadet

Innovative stents and scaffolds: potential of new technologies for your cathlab

19 May 2015 – From EuroPCR 2015

Dr. Christoph K. Naber

Chairperson

Christoph K. Naber

Theme 3: innovation in percutaneous tricuspid valve intervention

18 Sep 2016 – From PCR London Valves 2016

Chairperson

Steven Bolling
Corrado Tamburino

Chairperson

Corrado Tamburino

Planned and ongoing clinical trials: a status update from Cardialysis and the European Cardiovascular Research Institute (ECRI)

19 May 2016 – From EuroPCR 2016

Prof. Patrick W. Serruys

Chairperson

Patrick W. Serruys
Dr. Pascal Vranckx

Chairperson

Pascal Vranckx

Vulnerable plaque: future directions

19 May 2016 – From EuroPCR 2016

Panellists: T. Akasaka, K. Al-Shaibi, V. Farooq, D. Holmes, P.G. Steg and R. Virmani

Consult the session video on vulnerable plaque: future directions from EuroPCR 2016.

BRS: evolving technologies and applications

19 May 2016 – From EuroPCR 2016

Mohamed Abdel-Wahab

Chairperson

Mohamed Abdel-Wahab

The year in intervention: essential publications from the EuroIntervention Journal and the European Heart Journal

18 May 2016 – From EuroPCR 2016

Prof. Patrick W. Serruys

Chairperson

Patrick W. Serruys

EuroPCR 2016: Keynote lecture

18 May 2016 – From EuroPCR 2016

Consult this Keynote lecture on early percutaneous intervention for valvular disease - an opportunity for improving patient outcomes.

Dr. Javier Escaned

Chairperson

Javier Escaned
Dr. Jean Fajadet

Chairperson

Jean Fajadet

Bioresorbable vascular scaffolds in the real world – considering the ongoing evidence for safety and efficacy

18 May 2016 – From EuroPCR 2016

Keynote lectures

21 Jan 2016 – From AsiaPCR/SingLIVE 2016

Consult this Keynote lecture from AsiaPCR/SingLIVE 2016, which includes the following lectures:

Session objectivesLatest imaging and physiological assessment in percutaneous coronary interventionsPCI vs CABG for left main and MVD: Beyond SYNTAX, PRECOMBAT, BEST and combined Patient-level Meta-AnalysisCoronary Artery Disease: from prevention to preventive PCIKey learnings